Traditional, 10-Year MOC Exam
James P. Daubert, MD, Chair
Dr. Daubert is a Professor of Medicine with tenure at Duke University School of Medicine, member of the Duke Clinical Research Institute faculty, and Associate Director of the Heart Center at Duke University Medical Center. He is Board Certified in Internal Medicine, Cardiology, and Clinical Cardiac Electrophysiology.
Dr. Daubert founded and developed the EP program at University of Rochester beginning in 1992 until 2009. He returned to Duke in 2009 as Chief of the Section of Cardiac Electrophysiology serving until 2019. His research interests include sudden cardiac death, ICD/CRT indications and programming, inherited arrhythmias, sports cardiology, and atrial fibrillation. He has served on the MADIT Executive Committees, and numerous other Steering, Events and Data Monitoring committees. He chaired the Heart Rhythm Society Clinical Cardiology Electrophysiology Program Director Subcommittee, and is Vice Chair of the Education Committee.
He was awarded the Simon Dack Award for Outstanding Scholarship from JACC in 2010, and Elite Reviewer status multiple years. He is the Associate Editor of JACC Clinical Electrophysiology, Senior Consulting Editor at JACC Heart Failure, and Associate Editor for Journal of Interventional Cardiac Electrophysiology. He is on the Editorial Boards at JACC, Heart Rhythm, Journal of Interventional Cardiac Electrophysiology, Pacing and Clinical Electrophysiology, American Journal of Cardiology, Journal of Electrocardiology, and American Heart Journal. Outside of work he enjoys fishing and hockey, has coached youth hockey coach and been a volunteer physician for Somos Amigos in the Dominican Republic for 15 years receiving a Lifetime Achievement Award.
He attended Williams College (cum laude), then received his medical degree at Thomas Jefferson University. He received his postgraduate medical training at Duke, serving as Medicine Chief Resident 1988-1989.
As of May 2024, Dr. Daubert reported the following external relationships:
Funding for clinical trial expenses, salary support and staff, paid to Duke University, from the following companies:
- Medtronic, for a study to test cardiac resynchronization therapy (CRT) devices which contain the AdaptivCRT algorithm compared to standard devices in CRT for patients with normal atrioventricular conduction and left bundle branch block, receiving funding for expenses, salary support and staff
- Boston Scientific, to study the role of antitachycardia pacing in primary prevention patients indicated for implantable cardioverter-defibrillator (ICD) therapy and programmed according to current guidance of higher rate cut-offs and therapy delays, receiving funding for expenses and staff
Service on data and safety monitoring boards for the following companies, with honoraria:
- Actus, for service as a safety monitoring officer
- Affera, for service on a clinical events committee
- Biosense Webster, for service on three events committees
- Cordis, for service on a clinical events committee
- Philips, for service on a clinical events committee
- Syneos, for the RESTORE-1 (FLE-007) clinical events committee
- The National Institutes of Health Cardiothoracic Surgery Network, for service as a data and safety monitoring board member
- The National Institutes of Health/National Heart, Lung, and Blood Institute, for service as a data and safety monitoring board member for a His-bundle corrective pacing in heart failure study
Service on a research-related expert panel or advisory board for the following companies, with honoraria:
- Boston Scientific, for advising on design of an automatic defibrillator implantation trial-subcutaneous implantable cardioverter defibrillator, without compensation; for advising on a study the role of antitachycardia pacing in primary prevention patients indicated for ICD therapy and programmed according to current guidance of higher rate cut-offs and therapy delays, receiving honoraria
- Medtronic, for serving on an advisory board for quality and recalls, receiving honoraria
- Sorin, for a heart failure study steering committee, receiving honoraria
Industry-supported continuing medical education supported by the following, paid to Duke University, with compensation for travel expenses and honoraria:
- Abbott
- Boston Scientific
- Medtronic
Work as an author or editor for the following companies, with compensation as listed:
- Wiley-Blackwell, receiving compensation as an editor
- McGraw Hill, receiving compensation for authorship
Dr. Daubert serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- The Heart Rhythm Society, Education Committee, chair, receiving reimbursement for travel expenses
Emile Daoud, MD
Dr. Daoud is Professor, Internal Medicine at the Wexner Medical Center at The Ohio State University in Columbus, Ohio. He serves as the Chief of Cardiac Electrophysiology since 2007. He is board certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology.
From 1998 to 2007, Dr. Daoud was Director of Electrophysiology Research with the Midwest Research Foundation and worked as a Clinical Electrophysiologist with MidOhio Cardiology at Riverside Methodist Hospital, before joining The Ohio State University in 2007. Prior to that, following fellowship training, he was Assistant Professor at the University of Michigan for three years before relocating to Columbus, Ohio.
Dr. Daoud has published more than 150 manuscripts and has a particular interest in ablation of atrial and ventricular arrhythmias and device therapy, including biventricular pacing, subcutaneous defibrillators, and leadless pacing systems. He is currently a Fellow of the American College of Cardiology and a Fellow of the Heart Rhythm Society, as well as a member of the American Heart Association. He has been listed as America's Best Doctors in the U.S. News and World Report, a Top 10 faculty educator at The Ohio State University Medical Center and has served on numerous national steering committees and advisory boards, including serving as a member of the American Board of Internal Medicine Cardiovascular Board Clinical Cardiac Electrophysiology Exam Committee.
Dr. Daoud received his undergraduate degree from University of Notre Dame, and his medical degree from the University of Cincinnati. He then completed internal medicine training at The Johns Hopkins Hospital (1988-1991) in Baltimore, Maryland, and cardiology fellowship and subspecialty training in electrophysiology at the University of Michigan (1991-1995) in Ann Arbor, Michigan.
As of February 2024, Dr. Daoud reported the following external relationships:
Funding for clinical trial expenses and staff, paid to the Ohio State University, from the following companies:
- Affera, for a trial on pulsed-field ablation for atrial fibrillation
- Medtronic, for a trial on pulsed-field ablation for atrial fibrillation
- S4Medical, for an esophageal deviation study
Attendance at investigators’ meetings, with compensation for travel expenses and honoraria from the following companies:
- S4Medical, for an esophageal deviation study
Service on a research-related expert panel or advisory board for the following companies, with compensation for travel expenses and honoraria:
- Biosense Webster, advising on design of an investigational device exemption and subsequent clinical trial with new mapping tool for atrial fibrillation rotors
- Haemonetics, advising on vascular access
Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with compensation for travel expenses and honoraria:
- S4Medical, for an esophageal deviation study
Dr. Daoud serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- S4Medical, board member, inventor of its esophageal protection device for atrial fibrillation ablation procedures, receiving consulting fees and stock equity
- The American College of Cardiology, associate editor, receiving honoraria
Nathan A. Mark Estes III, MD
Dr. Estes is Professor of Medicine at Tufts University School of Medicine and Director of the Cardiac Arrhythmia Service at Tufts Medical Center, Boston, Massachusetts. He is board certified in Internal Medicine, Cardiovascular Disease and Clinical Cardiac Electrophysiology.
Dr. Estes is a member of the American Board of Internal Medicine Cardiovascular Board Clinical Cardiac Electrophysiology Exam Committee and has served on the Examination Writing Committee for the International Board of Heart Rhythm Examiners. He has served as the President of the Boston Board and Northeast Affiliate of the American Heart Association (AHA), Chairman of the AHA Council on Clinical Cardiology, and President of the Heart Rhythm Society. Dr. Estes has co-Chaired the Performance Measure Writing Committee of the American College of Cardiology (ACC) and AHA Atrial Fibrillation Performance Measures. He has served on the Performance Measures Committee of the Heart Rhythm Society and on the Quality Metrics Task Force of the ACC.
Dr. Estes is the Editor-in-Chief of UpToDate®in Cardiology. He has received multiple awards and honors, including being elected to Alpha Omega Alpha at the University of Cincinnati, the University of Pennsylvania Award of Merit, Moses Brown School Distinguished Achievement Award, the AHA Paul Dudley White Award and the Distinguished Leadership Award of the AHA. Dr. Estes also has been recognized with the President's Award of the Heart Rhythm Society (2013), the Distinguished Achievement Award of the European Cardiac Arrhythmia Society (2014) and the AHA Distinguished Achievement Award (2014).
Dr. Estes received his undergraduate degree from the University of Pennsylvania and his medical degree from the University of Cincinnati. He completed medical training at the Deaconess Hospital, cardiology training at Tufts Medical Center, and clinical cardiac electrophysiology training at Massachusetts General Hospital.
As of July 2023, Dr. Estes reported the following external relationships:
Work funded by educational grants from industry, paid to Dr. Estes, from the following companies:
- Boston Scientific, receiving salary support for director of an educational course for fellows
- Medtronic, receiving salary support for a safety and quality panel
Work as an author or editor for the following companies, with compensation as listed:
- UpToDate®, receiving compensation as editor-in-chief of the cardiovascular section
Michael Lloyd, MD
Dr. Lloyd is a Professor of Medicine and the lab director for Emory University Hospital Cardiac Electrophysiology Center. He is the immediate past director of the Electrophysiology Fellowship Program at Emory and serves as the Vice Chair of the Heart Rhythm Society's Digital Education Committee. He is board certified in cardiovascular disease and clinical cardiac electrophysiology.
As of July 2023, Dr. Lloyd reported the following external relationships:
Funding for clinical trial expenses and staff, paid to Emory University, from the following companies:
- Boston Scientific
- Medtronic
Service on a research-related advisory board for the following companies, with compensation for travel expenses and honoraria:
- Boston Scientific
Work funded by educational grants from industry, paid to Emory University, from the following companies:
- Biosense Webster, providing fellowship funding including staff and expenses.
Providing FDA-required training in the use of devices with compensation from the following companies:
- Medtronic, receiving honoraria and reimbursement for travel expenses.
Babak Nazer, MD
Dr. Nazer is a board certified cardiac electrophysiologist and Associate Professor of Medicine and Bioengineering at the University of Washington.
As of May 2024, Dr. Nazer reported the following external relationships:
Service on data and safety monitoring boards for the following companies, with compensation for travel expenses:
- Baim Cardiovascular Research Institute, Clinical Endpoints Committee.
Service on a research-related advisory board for the following companies, with compensation for travel expenses and honoraria:
- Biosense Webster
Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with honoraria:
- Siemens